Insider trading

Period: 120 months Stock: QTRX Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

377 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

377 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

377 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

377 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
377 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
377 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

377 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
14 May 2024
OLSON LAURIE J Director
Sold on a plan
$25.47K 1,500 at 16.98
9.8%
Planned (10b5-1)
1 Apr 2024
OLSON LAURIE J Director
Sold on a plan
$23.50K 1,000 at 23.50
6.2%
Planned (10b5-1)
14 Feb 2024
OLSON LAURIE J Director
Sold on a plan
$36.53K 1,500 at 24.35
9.0%
Planned (10b5-1)
2 Jan 2024
OLSON LAURIE J Director
Sold at will
$26.91K 1,000 at 26.91
5.6%
Not planned
14 Nov 2023
OLSON LAURIE J Director
Sold on a plan
$32.84K 1,500 at 21.89
9.8%
Planned (10b5-1)
1 Aug 2022
Toloue Masoud President & CEO
Sold, plan not stated
$6.96K 446 at 15.61
0.5%
1 Aug 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.26K 401 at 15.61
1.1%
1 Aug 2022
DOYLE MICHAEL A CFO and Treasurer
Sold, plan not stated
$577.74 37 at 15.61
0.2%
13 Jul 2022
DOYLE MICHAEL A CFO and Treasurer
Sold, plan not stated
$7.88K 434 at 18.16
2.3%
5 Jul 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated
$15.91K 960 at 16.57
0.1%
5 Jul 2022
Toloue Masoud President & CEO
Sold, plan not stated
$7.16K 432 at 16.57
0.5%
5 Jul 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.41K 387 at 16.57
1.0%
13 Jun 2022
Toloue Masoud President & CEO
Sold, plan not stated
$84.96K 5,564 at 15.27
6.4%
2 Jun 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated
$12.44K 712 at 17.47
0.1%
2 Jun 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.61K 378 at 17.47
1.0%
2 May 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated 2×
$14.51K 649 at 22.36
0.1%
2 May 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$9.59K 429 at 22.36
1.1%
1 Apr 2022
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated
$25.86K 868 at 29.79
0.1%
1 Apr 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$15.61K 524 at 29.79
1.7%
1 Apr 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$7.78K 261 at 29.79
0.7%
1 Apr 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$5.09K 171 at 29.79
0.8%
23 Mar 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$97.98K 3,266 at 30.00
5.6%
1 Mar 2022
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated 2×
$18.53K 589 at 31.46
0.1%
1 Mar 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$11.67K 371 at 31.46
1.2%
1 Mar 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$8.40K 267 at 31.46
0.7%
1 Mar 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.22K 166 at 31.46
0.7%
9 Feb 2022
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated
$47.70K 1,364 at 34.97
0.2%
9 Feb 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$16.82K 481 at 34.97
1.5%
9 Feb 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$11.12K 318 at 34.97
0.8%
9 Feb 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$10.21K 292 at 34.97
1.3%
4 Feb 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$100.95K 3,266 at 30.91
5.3%
2 Feb 2022
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated 2×
$18.53K 589 at 31.46
0.1%
2 Feb 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$11.67K 371 at 31.46
1.2%
2 Feb 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$8.40K 267 at 31.46
0.7%
2 Feb 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.22K 166 at 31.46
0.7%
31 Jan 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$97.98K 3,266 at 30.00
5.1%
3 Jan 2022
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated
$155.68K 3,715 at 41.91
0.4%
3 Jan 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$14.88K 355 at 41.91
0.9%
3 Jan 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$14.75K 352 at 41.91
1.1%
3 Jan 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$6.24K 149 at 41.91
0.6%
29 Dec 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$67.86K 1,667 at 40.71
6.7%
1 Dec 2021
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated 2×
$149.48K 3,710 at 40.29
0.4%
1 Dec 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$14.22K 353 at 40.29
0.9%
1 Dec 2021
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$14.10K 350 at 40.29
1.1%
1 Dec 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.92K 147 at 40.29
0.6%
19 Nov 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$75.92K 1,667 at 45.54
6.3%
10 Nov 2021
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated 3×
$275.90K 5,000 at 55.18
0.6%
5 Nov 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$488.85K 8,535 at 57.28
18.1%
4 Nov 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$57.00 1 at 57.00
0.0%
2 Nov 2021
HRUSOVSKY E KEVIN Chairman and CEO
Sold, plan not stated 2×
$184.38K 3,505 at 52.61
0.4%
Showing 1–50 of 377. Page 1 of 8 Older →